scholarly journals The role of prescription drugs in female overactive bladder syndrome—A population‐wide cohort study

2019 ◽  
Vol 29 (2) ◽  
pp. 189-198 ◽  
Author(s):  
Wolfgang Umek ◽  
Andreas Gleiss ◽  
Barbara Bodner‐Adler ◽  
Berthold Reichardt ◽  
Christoph Rinner ◽  
...  
Keyword(s):  
Cohort Study ◽  
Overactive Bladder ◽  
Prescription Drugs ◽  
Overactive Bladder Syndrome

scholarly journals Overactive Bladder Syndrome and the Potential Role of Prostaglandins and Phosphodiesterases: An Introduction

2013 ◽  
Vol 5 (4) ◽  
Author(s):  
Mohammad Sajjad Rahnama'i ◽  
Gommert A. van Koevringe ◽  
Philip E. Van Kerrebroeck
Keyword(s):  
Overactive Bladder ◽  
Potential Role ◽  
Overactive Bladder Syndrome

scholarly journals OP28.05: Association of uterine leiomyoma and overactive bladder syndrome: a cohort study

2017 ◽  
Vol 50 ◽  
pp. 140-140
Author(s):  
M. Koch ◽  
T. Rauchenwald ◽  
Y.T. Bader ◽  
S. Schwab ◽  
H. Koelbl ◽  
...  
Keyword(s):  
Cohort Study ◽  
Overactive Bladder ◽  
Uterine Leiomyoma ◽  
Overactive Bladder Syndrome

scholarly journals Overactive Bladder Syndrome is Associated With Detrusor Overactivity and Abnormal Voiding Pattern in Nulliparous Women

2020 ◽  
Author(s):  
Jessica Fang ◽  
Ming-Ping Wu ◽  
Yu-Chun Yen ◽  
Jeng-Cheng Wu ◽  
Hung-Yen Chin
Keyword(s):  
Overactive Bladder ◽  
Overactive Bladder Syndrome ◽  
Inclusion Criteria ◽  
Pregnancy And Childbirth ◽  
Nulliparous Women ◽  
Urethral Closure ◽  
Recorded Data ◽  
Voiding Pattern ◽  
Spontaneous Delivery

Abstract Pregnancy and childbirth are frequently associated with overactive bladder syndrome (OAB). However, the role of parous effects in OAB among nulliparous (NP) women remains controversial. This study investigated abnormal voiding patterns and DO among NP woman with OAB in comparison with parous women. From August 2011 to December 2018, 906 patients met the inclusion criteria for participation and were divided into three groups: 221 patients in the NP group, 571 patients in the normal spontaneous delivery (NSD) group, and 114 patients in the cesarean section (CS) group. Urodynamic study (UDS) examinations were performed, and the presence of DO, abnormal voiding patterns, and maximum urethral closure pressure (MUCP) were recorded. Data were analyzed using analysis of variance, χ2 tests, and independent t tests. Compared with parous women in the NSD and CS groups, patients in the NP group had a significantly higher prevalence of abnormal voiding patterns, DO and MUCP. Furthermore, abnormal voiding patterns were significantly associated with DO and MUCP respectively, especially in the NP group. We hypothesized that hypertonicity or poor relaxation of the pelvic muscle in NP women may cause functional BOO, which is related to their OAB.

Physiotherapy and behavior therapy for the treatment of overactive bladder syndrome: a prospective cohort study

2017 ◽  
Vol 295 (5) ◽  
pp. 1211-1217 ◽  
Author(s):  
Martina Wolz-Beck ◽  
Christl Reisenauer ◽  
Giselle E. Kolenic ◽  
Sabine Hahn ◽  
Sara Y. Brucker ◽  
...  
Keyword(s):  
Cohort Study ◽  
Overactive Bladder ◽  
Behavior Therapy ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Overactive Bladder Syndrome ◽  
And Behavior

1968 THE ROLE OF URINARY NEUROTROPHIC FACTORS IN OVERACTIVE BLADDER SYNDROME

2012 ◽  
Vol 187 (4S) ◽  
Author(s):  
Tiago Antunes-Lopes ◽  
Rui Pinto ◽  
Sérgio Carvalho-Barros ◽  
Francisco Botelho ◽  
Paulo Diniz ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Neurotrophic Factors ◽  
Overactive Bladder Syndrome

Current Management of Urinary Incontinence

2004 ◽  
Vol 17 (2) ◽  
pp. 103-114
Author(s):  
Tanya C. Knight-Klimas
Keyword(s):  
Health Care ◽  
Urinary Incontinence ◽  
Overactive Bladder ◽  
Stress Incontinence ◽  
Health Care Professionals ◽  
Overactive Bladder Syndrome ◽  
Current Management ◽  
Different Types ◽  
Functional Incontinence

Urinary incontinence is an underreported, underdiagnosed, and undertreated condition erroneously thought by many patients to be a normal part of aging. This article briefly discusses transient urinary incontinence and then focuses on the different types of established incontinence. Specifically, the article discusses preferred terminology associated with urinary incontinence and describes the different types, causes, nonpharmacologic options, and pharmacologic options for managing overactive bladder syndrome, stress incontinence, and overflow incontinence. It briefly discusses mixed urinary incontinence and functional incontinence. The role of the pharmacist in working with patients, caregivers, and other health care professionals to optimize management of urinary incontinence is discussed throughout.

Sign in / Sign up

Export Citation Format

Share Document